Bird & Bird advises Synarc Inc. in the acquisition of IôDP


Marc Baffreau, partner, with the assistance of Cristian Rawlins, associate, advised Synarc Inc., in the acquisition of the French company IôDP, a medical imaging company specialised in cardiovascular and neurovascular disease.

Synarc Inc. is a leader in providing highly specialised medical imaging and molecular marker services for global clinical trials.

The specific nature of the medical imaging services business required an extensive review by Bird & Bird specialists of substantial different legal issues, prior to the completion of the acquisition of IôDP.

The financial terms of the transaction are note being disclosed. Marc Baffreau, partner at Bird & Bird, stated:

"We have advised Synarc Inc. throughout different stages of this transaction. The specific nature of the medical imaging services business gave us the opportunity to work with our other teams specialised in life science and IP/IT issues, prior to completion of the transaction. Notwithstanding, our main role involved activities that concentrated on the purchase of the shares held by the significant shareholders of IôDP (e.g., its managers and 3i). We hope to continue our relationship with the Synarc Inc. team as well as with the managers of their new acquisition”.

For more information, please contact Marc Baffreau on +33 (0) 1 42 68 60 00 or Larry Cattle on + 44 (0) 20 7415 6156.